Shanghai Medicilon Inc. (SHA:688202)
China · Delayed Price · Currency is CNY 87.00
+9.85 (12.77%)
At close: Jul 10, 2026
Shanghai Medicilon Market Cap
Shanghai Medicilon has a market cap or net worth of 11.44 billion as of July 10, 2026. Its market cap has increased by 150.56% in one year.
Market Cap
11.44B
Enterprise Value
11.17B
Revenue
1.26B
Ranking
n/a
PE Ratio
n/a
Stock Price
87.00
Market Cap Chart
Since November 5, 2019, Shanghai Medicilon's market cap has increased from 4.40B to 11.44B, an increase of 159.98%. That is a compound annual growth rate of 15.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 11.44B | 54.26% |
| Dec 31, 2025 | 7.42B | 83.97% |
| Dec 31, 2024 | 4.03B | -56.21% |
| Dec 29, 2023 | 9.21B | -50.52% |
| Dec 30, 2022 | 18.61B | -38.26% |
| Dec 31, 2021 | 30.15B | 209.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 5, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anhui Anke Biotechnology (Group) | 13.50B |
| Jinyu Bio-technology | 13.31B |
| InventisBio | 12.96B |
| Staidson (Beijing) BioPharmaceuticals | 11.57B |
| Inner Mongolia Furui Medical Science | 11.42B |
| Tibet Cheezheng Tibetan Medicine | 11.36B |
| Beijing Hotgen Biotech | 10.94B |
| Chengzhi | 10.63B |